We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease

Steven Kesten, MD; Inge Leimer, PhD; Michele Jara, PhD
JAMA. 2009;301(12):1223-1226. doi:10.1001/jama.2008.949.
Text Size: A A A
Published online


To the Editor: Dr Singh and colleagues1 conducted a meta-analysis of the relationship between inhaled anticholinergic medications and major cardiovascular adverse events. This study's findings were contrary to results from a previously published meta-analysis.2 The study by Singh et al relied on information obtained from medical journals, Web sites of pharmaceutical companies, and regulatory authorities. Publications of clinical trials are summary reports that by necessity omit many details. Infrequent adverse events are often not reported because the small number observed in a single trial is not informative. The study by Singh et al identified 58 cases of major cardiovascular events from 8 published reports of 11 placebo-controlled tiotropium trials (excluding the 2000 study by Casaburi et al3 and the study by Donohue et al,4 which resulted in double counting of patients by Singh et al). Even if all trials are published, meta-analyses of published reports remain vulnerable to unreported cases.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




March 25, 2009
Yuji Oba, MD
JAMA. 2009;301(12):1223-1226. doi:10.1001/jama.2008.947.
March 25, 2009
Henry D. Covelli, MD
JAMA. 2009;301(12):1223-1226. doi:10.1001/jama.2008.948.
March 25, 2009
Katherine E. Hodgin, MD; James P. Maloney, MD
JAMA. 2009;301(12):1223-1226. doi:10.1001/jama.2008.950.
March 25, 2009
Sonal Singh, MD, MPH; Yoon K. Loke, MBBS, MD; Curt D. Furberg, MD, PhD
JAMA. 2009;301(12):1223-1226. doi:10.1001/jama.2008.951.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.